WASHINGTON |
(Reuters) - The chairwoman of an advisory panel to the U.S. Food and
Drug Administration said she will withdraw from a drug industry
conference after the consumer rights group Public Citizen leveled
conflict-of-interest allegations against her.Dr. Lynn Drake, a lecturer at Harvard Medical School and current chairwoman of the panel that advises the FDA on drugs to treat skin and eye conditions, was scheduled to speak in February at a conference whose aim, according to its brochure, is to help companies "walk away with strategies to successfully present before a committee and avoid potential roadblocks."
continue to read here